Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Genetic Basis For Metabolic Diseases Detected

30.06.2004


Oxford geneticists have closed in on the genetic basis for risk factors of metabolic diseases such as hypertension, obesity and diabetes.



Studying 1,300 patients and healthy volunteers from over 400 families across Oxfordshire, the research team located several variations in the DNA sequence of the lipid phosphate SHIP2 gene which are associated with an increased risk for a cluster of common and increasingly frequent disorders, referred to as the ’metabolic syndrome’ or ’Syndrome X’. Syndrome X, whose genetic basis is as yet unexplained, includes obesity, hypertension, type 2 diabetes and dyslipidaemia, and is a common risk factor for cardiovascular disease and atherosclerosis.

SHIP2 is a key cellular regulator of the biological effects of the hormone insulin which lowers the levels of blood sugar. Reduced insulin action, also called insulin resistance, is the common feature of the pathological components of the Syndrome X.


Dr Dominique Gauguier, Wellcome Senior Research Fellow at the Wellcome Trust Centre for Human Genetics at Oxford University, and his team identified 50 sequence variants in SHIP2 which were used to test their possible association with the different disease components of the Syndrome X diagnosed in the patients.

Dr Gauguier said: ’Epidemiological studies find that obesity, hypertension and type 2 diabetes are frequently associated, but we do not understand the exact causal relationships between these diseases, though environmental factors, for example diet and lifestyle, certainly play an important role. ‘Genetic studies have generally looked at these diseases independently. Our recent findings, which are among the first demonstrations of an association between gene sequence variants and the disease components of the Syndrome X, emphasise the need of extensive and accurate biological information in patients for tackling the genetics of metabolic disorders.’

’Another original feature of our research is that we have actually been able to translate our previous studies in a rat model of the Syndrome X, which carries a functional mutation in SHIP2, to human genetics.

’The next step is now to attempt a replication of our results in other large groups of patients characterised for features of the metabolic syndrome. Six research groups around the world are currently helping us do that.

’If we are correct, we may have found a tool for screening patients to see whether they are at increased risk of developing diabetes, hypertension, obesity or cardio-vascular disease. Our findings may have great potential for the prevention of metabolic disorders and, in predicting disease onset, may provide an opportunity for early intervention through changes in diet and lifestyle in people carrying the sequence variants in SHIP2.’

Barbara Hott | alfa
Further information:
http://www.ox.ac.uk
http://diabetes.diabetesjournals.org

More articles from Studies and Analyses:

nachricht Multi-year study finds 'hotspots' of ammonia over world's major agricultural areas
17.03.2017 | University of Maryland

nachricht Diabetes Drug May Improve Bone Fat-induced Defects of Fracture Healing
17.03.2017 | Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

Researchers make flexible glass for tiny medical devices

24.03.2017 | Materials Sciences

Laser activated gold pyramids could deliver drugs, DNA into cells without harm

24.03.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>